Harvard Bioscience Inc.
HBIO
Market Cap$20.5M
Close$
$0.40
9.6% downside
Current Fair Value
9.6% downsideOvervalued by 9.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.50 Million |
|---|---|
| Enterprise Value | $26.99 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.28 |
| Beta | 1.55 |
| Outstanding Shares | 44,096,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | -0.04 |
| Price to Sales | 0.22 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.3 |
| Enterprise Value to EBIT | -0.63 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 0.81 |
Revenue Sources
No data
Insider Trades
ESG Score
No data